Please assess the completion status of the following clinical trial:

Trial Title: Mission Reconnect-Veterans and Their Partners to Manage Pain and PTSD (MR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* English-speaking Veterans with chronic musculoskeletal pain.~* Veteran is considered to have chronic musculoskeletal pain if he or she meeting either of two validated criteria:~  * (1) Having 2+ occurrences of any of targeted musculoskeletal ICD-9-CM codes likely to represent chronic pain recorded at visits separated by at least 30 days within past six months~ * (2) Having high impact chronic pain = 2+ occurrences of targeted musculoskeletal ICD-9-CM codes separated by at least 30 days within the past six months previous to study recruitment and two or more pain scores greater than or equal to 4 separated by at least 30 days within past six months.~* For pain scores, the investigators will use the 0-10 numeric pain rating scale that is routinely collected at the VA.~  * The investigators will count two ICD-9-CM codes or pain scores recorded on the same day as one code/score.~ * Veteran is considered to have PTSD if he or she has a flag in his/her record indicating confirmed condition by the VA Compensation and Benefits program, has at least two outpatient visits in the year with the primary diagnosis being listed as PTSD (ICD-9-CM code 309.81) and/or had PTSD listed on the problem list\], Veteran must also have PTSD (defined by PTSD diagnosis-ICD-9-CM 309.81), the ability to access and use an electronic platform (e.g. Mobile device, internet, DVD) for MR delivery, with a willing partner to also participate in the study and MR program.~Exclusion Criteria:~* Moderate to severe traumatic brain injury (TBI)~* Diagnosis or documented treatment for psychosis in previous 6 months~* Currently in substance use disorder treatment~* Non-English speaking~* Visual, hearing, cognitive impairment that prevent participation or ability to consent~* And/or lack of access to internet service~* These individuals will be excluded due to medical, language, and technology access issues that would prevent safe and full study participation.~* Pain and PTSD treatment will not be factored as an inclusion/exclusion criteria but will be evaluated as covariates.~* Potential participants who screen for aggression or violence will also be excluded from study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treatment arm - Veteran (Type: ACTIVE_COMPARATOR): Treatment Arm: MR is an user-driven, dyadic, self-care management program developed with National Institute of Mental Health (NIMH) funding (R43/44) for use by Veterans and their selected partners, individually or together, to reduce pain and distress and support physical, mental, and relationship health. MR was designed for Veterans who face obstacles accessing formal mental health services. It can also be used to complement formal services. MR is a patient-centered intervention, allowing users to determine the pace at which to proceed in each program component. MR Content. The program provides video and audio instruction in a set of 11 evidence-based wellness.
- Control arm - Veteran (Type: NO_INTERVENTION): Usual Care Waitlist Control Arm: For ethical reasons, this study will use a waitlist control arm to ultimately provide all participants exposure to the MR intervention. Dyads in the control arm will participate in all assessments like those in the treatment group, however, they will be asked to agree to not access the public web site during their participation. Wait-list control participants will be instructed to seek advice about treatment from their providers. Other than this initial advice, there will be no attempt by study personnel to influence condition management unless an issue (i.e., suicidal ideation) arises. The control condition will account for potential temporal effects that occur from passage of time (brief), and expectation effects associated with anticipation of MR participation. The control group will receive access to MR after they complete data collection.
- Treatment arm - Partner (Type: EXPERIMENTAL): Treatment Arm: MR is an user-driven, dyadic, self-care management program developed with NIMH funding (R43/44) for use by Veterans and their selected partners, individually or together, to reduce pain and distress and support physical, mental, and relationship health. MR was designed for Veterans who face obstacles accessing formal mental health services. It can also be used to complement formal services. MR is a patient-centered intervention, allowing users to determine the pace at which to proceed in each program component. MR Content. The program provides video and audio instruction in a set of 11 evidence-based wellness.
- Control arm - Partner (Type: NO_INTERVENTION): Usual Care Waitlist Control Arm: For ethical reasons, this study will use a waitlist control arm to ultimately provide all participants exposure to the MR intervention. Dyads in the control arm will participate in all assessments like those in the treatment group, however, they will be asked to agree to not access the public web site during their participation. Wait-list control participants will be instructed to seek advice about treatment from their providers. Other than this initial advice, there will be no attempt by study personnel to influence condition management unless an issue (i.e., suicidal ideation) arises. The control condition will account for potential temporal effects that occur from passage of time (brief), and expectation effects associated with anticipation of MR participation. The control group will receive access to MR after they complete data collection.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete